Sisram Medical Ltd
SRAMF
$0.535
$0.5350.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 82.74M | 82.74M | 90.19M | 90.19M | 84.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 82.74M | 82.74M | 90.19M | 90.19M | 84.37M |
| Cost of Revenue | 33.06M | 33.06M | 34.51M | 34.51M | 31.71M |
| Gross Profit | 49.67M | 49.67M | 55.68M | 55.68M | 52.66M |
| SG&A Expenses | 40.12M | 40.12M | 42.78M | 42.78M | 39.77M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.17M | 1.17M | 2.39M | 2.39M | 1.60M |
| Total Operating Expenses | 78.38M | 78.38M | 83.61M | 83.61M | 77.11M |
| Operating Income | 4.35M | 4.35M | 6.59M | 6.59M | 7.25M |
| Income Before Tax | 5.90M | 5.90M | 8.91M | 8.91M | 7.36M |
| Income Tax Expenses | 1.40M | 1.40M | 1.13M | 1.13M | 760.50K |
| Earnings from Continuing Operations | 4.49M | 4.49M | 7.78M | 7.78M | 6.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.28M | -1.28M | -695.00K | -695.00K | -1.13M |
| Net Income | 3.21M | 3.21M | 7.09M | 7.09M | 5.48M |
| EBIT | 4.35M | 4.35M | 6.59M | 6.59M | 7.25M |
| EBITDA | 7.12M | 7.12M | 9.40M | 9.40M | 10.06M |
| EPS Basic | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 468.34M | 468.34M | 468.34M | 468.34M | 468.34M |
| Average Diluted Shares Outstanding | 468.34M | 468.34M | 468.34M | 468.34M | 468.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 66.67% | 66.67% | -- |